恶性脑肿瘤手术中使用术中MRI是否构成医疗负担?基于MarketScan数据库的匹配分析
研究利用MarketScan数据库(2008–2020年)分析6640例恶性脑肿瘤开颅切除术患者,其中465例(7%)使用术中MRI,使用率每年增加0.7%。使用术中MRI者 index 住院并发症低于未使用者(14% vs 19%,p=0.04),术后6个月和1年急诊就诊率无差异,6个月和1年出院后支付无显著差异。结论认为术中MRI未导致 index 住院、术后6个月和1年支付增加。
要点
- 术中MRI使用率在研究期间每年增加0.7%,465/6640例(7%)使用。
- 未使用术中MRI者 index 住院并发症高于使用者(19% vs 14%,p=0.04)。
- 术后6个月和1年急诊就诊率在两组间无差异。
核心结论
- 恶性脑肿瘤开颅切除术中使用术中MRI未导致 index 住院、术后6个月和1年支付增加。
研究设计与样本
- 回顾性匹配分析,查询MarketScan数据库2008至2020年数据,纳入年龄≥18岁接受开颅切除术且至少随访1年的恶性脑肿瘤患者。
主要发现
- 6640例恶性脑肿瘤开颅切除术患者中,465例(7%)使用术中MRI,研究期间使用率每年增加0.7%。
- 未使用术中MRI者 index 住院并发症高于使用者(19% vs 14%,p=0.04)。
- 术后6个月和1年急诊就诊率在两组间无差异。
- 术后6个月支付两组无显著差异(未使用组81107美元 vs 使用组81458美元,p=0.26)。
- 术后1年支付两组无显著差异(未使用组132657美元 vs 使用组118113美元,p=0.12)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative magnetic resonance imaging (iMRI) is a useful adjunct for resection of primary malignant brain tumors (MBTs). The aim of our study is to investigate the impact of iMRI on health care utilization in patients who underwent craniotomy for resection of MBTs. MATERIALS AND METHODS: MarketScan database were queried using the ICD-9/10 and CPT 4th edition, from 2008 to 2020. We included patients ≥ 18 years of age who underwent a craniotomy with at-least one year follow-up. Outcomes were length of stay (LOS), discharge disposition, hospital/emergency room (ER) re-admissions, outpatient services, medication refills and corresponding payments. RESULTS: Of 6,640 patients who underwent craniotomy for MBTs, 465 patients (7%) had iMRI used during the procedure with 0.7% per year increase in iMRI use during the study period. Patients without iMRI use had higher complications at index hospitalization compared to those with iMRI use (19% vs. 14%, p = 0.04). There was no difference in the ER admission rates among the patients who underwent surgery with and without iMRI use at 6-months and 1-year after the index procedure. In terms of post-discharge payments, no significant differences were noted among the patients without and with iMRI use at 6-months ($81,107 vs. $ 81,458, p = 0.26) and 1-year ($132,657 vs. $ 118,113, p = 0.12). CONCLUSION: iMRI use during craniotomy for MBT gradually increased during the study period. iMRI did not result in higher payments at index hospitalization, 6-months, and 1-year after the index procedure.
引用
- Sharma M, Wang D, Palmisciano P, et al. Is intraoperative MRI use in malignant brain tumor surgery a health care burden? A matched analysis of MarketScan Database. J Neurooncol. 2022. PMID: 36289149. doi:10.1007/s11060-022-04142-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。